<unk>  is an human immunoglobulin that is FDA approved for the treatment of of infant botulism caused by toxin type A or B in patients below one year of age.   Common adverse reactions include skin rash, chills, muscle cramps, back pain, fever, nausea, vomiting, and wheezing.
Botulinum antitoxin
Botulinum toxin
IncobotulinumtoxinA
Rimabotulinumtoxinb
Rubratoxin
Ceruletide
Metreleptin
Neurotoxin